[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-343402-105":59,"doc-detail-343402-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","microrna-376a-3p-sensitizes-cpt-11-resistant-colorectal-cancer-by-enhancing-apoptosis-and-reversing-the-epithelial-to-mesenchymal-transition-emt-through-the-igf1rpi3kakt-pathway","MicroRNA-376a-3p sensitizes CPT-11-resistant colorectal cancer by enhancing apoptosis and reversing the epithelial-to-mesenchymal transition (EMT) through the IGF1R/PI3K/AKT pathway","","Colorectal cancer (CRC) remains a leading worldwide cancer burden, and CPT-11 is a key first-line therapy whose effectiveness is limited by drug resistance that drives recurrence and metastasis. CPT-11 resistance is linked to survival programs mediated by IGF1R and the PI3K/AKT pathway, with microRNAs often dysregulated in CRC. This study investigates miRNA-376a-3p as a contributor to CPT-11 resistance using knockdown/overexpression with western blot, RT-qPCR, flow cytometry, MTT, and migration assays. Results show miRNA-376a-3p sensitizes resistant CRC by inhibiting IGF1R-driven survival signaling and reversing EMT.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/microrna-376a-3p-sensitizes-cpt-11-resistant-colorectal-cancer-by-enhancing-apoptosis-and-reversing-the-epithelial-to-mesenchymal-transition-emt-through-the-igf1rpi3kakt-pathway/343402/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/microrna-376a-3p-sensitizes-cpt-11-resistant-colorectal-cancer-by-enhancing-apoptosis-and-reversing-the-epithelial-to-mesenchymal-transition-emt-through-the-igf1rpi3kakt-pathway/343402.png","ImageObject",300,407,{"name":92,"@type":93},"Rowan","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What problem does the study address in colorectal cancer therapy?","Question",{"text":112,"@type":113},"The study targets CPT-11 resistance in colorectal cancer, which worsens outcomes through tumor recurrence and metastasis.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which molecular pathway is central to the proposed mechanism?",{"text":117,"@type":113},"The mechanism focuses on the IGF1R/PI3K/AKT pathway and its role in cancer cell survival and drug resistance.",{"name":119,"@type":110,"acceptedAnswer":120},"How was miRNA-376a-3p evaluated experimentally?",{"text":121,"@type":113},"The study used knockdown and overexpression approaches combined with western blot, RT-qPCR, flow cytometry, MTT, and migration assays.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},343402,1790152996,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099514067415,"https://ap-avatar.wpscdn.com/avatar/100002539d78ffe74a7?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779092875211072502","Translational Oncology 50 (2024) 102125  \nContents lists available at ScienceDirect  \nTranslational Oncology  \njournal [homepage:](homepage: www.elsevier.com/locate/tranon)[ www.elsevier.com/locate/tranon](homepage: www.elsevier.com/locate/tranon)  \nOriginal Research  \nMicroRNA-376a-3p sensitizes CPT-11-resistant colorectal cancer by enhancing apoptosis and reversing the epithelial-to-mesenchymal transition (EMT) through the IGF1R/PI3K/AKT pathway  \nChikondi Jassia,**, Wei-Wen Kuo a,b,c, Yu-Chun Chang a, Tso-Fu Wangd,e, Tsung-Jung Hog,h, Dennis Jine-Yuan Hsieh i,j, Chia-Hua Kuok,l, Ming-Cheng Chenm,n, Chi-Cheng Lie,f,1, Chih-Yang Huang o,p,q,r,s,1,*  \na Department of Biological Science and Technology, China Medical University, Taichung, Taiwan b Ph.D. Program for Biotechnology Industry, China Medical University, Taichung, Taiwan, ROC c School of pharmacy, China Medical University, Taichung, Taiwan, ROC  \nd Department of Hematology and Oncology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan e School of Medicine Tzu Chi University, 701, Section 3, Chung-Yang Road, Hualien 97004, Taiwan  \nf Center of Stem Cell & Precision Medicine, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan g Chinese Medicine, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Tzu Chi University, Hualien, Taiwan  \nh Department of Medical Laboratory Science and Biotechnology, China Medical University, Taichung, Taiwan i School of Medical Laboratory and Biotechnology, Chung Shan Medical University, Taichung, Taiwan j Clinical Laboratory, Chung Shan Medical University Hospital, Taichung 402, Taiwan  \nk Laboratory of Exercise Biochemistry, University of Taipei, Taipei, Taiwan  \nl Department ofKinesiology and Health Science, College of William and Mary, Williamsburg, VA, USAm Department of Surgery, Division of Colorectal Surgery, Taichung Veterans General Hospital, Taichung, Taiwan n Faculty of Medicine, National Yang-Ming University, Taipei, Taiwan  \no Cardiovascular and Mitochondria related Diseases Research Center, Hualien Tzu Chi Hospital, Hualien 970, Taiwan p Graduate Institute of Biomedicine, China Medical University, Taichung, Taiwan  \nq Department of Biotechnology, Asia University, Taichung 413, Taiwan  \nr Center of General Education, Buddhist Tzu Chi Medical Foundation, Tzu Chi University of Science and Technology, Hualien 970, Taiwan s Department of Medical Research, China Medical University Hospital, China Medical University, Taichung 404, Taiwan  \nA R T I C L E I N F O  \nKeywords: Colorectal cancer CPT-11  \nCPT-11 resistance IGF1RmiRNA-376a-3p  \nA B S T R A C T  \nColorectal cancer (CRC) remains the third most prevalent type of cancer worldwide contributing to an estimated 10 % of all cancer cases. CPT-11 is one of the first-line drugs for CRC treatment. Unfortunately, the development of drug resistance significantly exacerbates the adverse impact of CRC. Consequent tumor recurrences and metastasis, years after treatment are the frequently reported incidences. MicroRNAs (miRNA) are short noncoding RNA with the functionality of gene suppression. The insulin-like growth factor type 1 receptor (IGF1R) is a tyrosine kinase receptor frequently upregulated in cancers and is associated with cell survival and drug resistance. MiRNAs are frequently reported to be dysregulated in cancers including CRC. Evidence suggests that dysregulated miRNAs have direct consequences on the biological processes of their target genes. We previously demonstrated that miRNA-376a-3p is upregulated in CPT-11responsive, CRC cells upon treatment with CPT-11. We therefore aimed to investigate the involvement of miRNA-376a-3p in CPT-11 resistance and its probable association with IGF1R-mediated cancer cell survival. Our experimental approach used knockdown and overexpression experiments supplemented with western blot, RT-qPCR, flow cytometry, MTT, and migration assays to achieve our aim. Our data reveals the m","cbCaiuvr8rgWmSom","https://ap.wps.com/l/cbCaiuvr8rgWmSom","pdf",15205374,15,"English","# Introduction\n## Experimental focus and study aim\n# Keywords and research context\n# Abstract overview\n## CPT-11 and CRC drug resistance\n## Role of miRNA-376a-3p and IGF1R/PI3K/AKT pathway","[{\"question\":\"What problem does the study address in colorectal cancer therapy?\",\"answer\":\"The study targets CPT-11 resistance in colorectal cancer, which worsens outcomes through tumor recurrence and metastasis.\"},{\"question\":\"Which molecular pathway is central to the proposed mechanism?\",\"answer\":\"The mechanism focuses on the IGF1R/PI3K/AKT pathway and its role in cancer cell survival and drug resistance.\"},{\"question\":\"How was miRNA-376a-3p evaluated experimentally?\",\"answer\":\"The study used knockdown and overexpression approaches combined with western blot, RT-qPCR, flow cytometry, MTT, and migration assays.\"}]","MicroRNA-376a-3p sensitizes CPT-11-resistant colorectal cancer by enhancing apoptosis and reversing the epithelial-to-mesenchymal transition (EMT) through the IGF1R/PI3K/AKT pathway | PDF",1790051069,38,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ee94842ec6f9d67d63e36d58e776cd21.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a4ac2991d23ae91610e6b7726dfdae5a.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/69bf5de9f31cdf1a16bc7471a87100bd.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a23e844b68d92a89d1aa9a833b1e7a27.webp",980,1306]